1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > IMS Country Review 2016: Austria

IMS Country Review 2016: Austria

  • July 2016
  • -
  • IMS Health
  • -
  • 81 pages

IMS Country Review™ 2016 provides comprehensive qualitative insights into a specific pharmaceutical market as well as showing sales trends over the last 5 years. Sales performance is analysed in terms of major corporations, therapeutic classes, major products and new product activity.

Table Of Contents

IMS Country Review 2016: Austria
SECTION 1: SYNOPSIS OF THE HEALTHCARE MARKET 5
CHANNELS OF DISTRIBUTION 6
AUSTRIA DATA COLLECTION 7
SECTION 2: COUNTRY SALES PERFORMANCE AND TRENDS 8
FIGURE 1: COUNTRY RANKING AMONGST 30 MARKETS WORLDWIDE 8
FIGURE 2: AUDITED MARKET TREND 9
FIGURE 3: LEADING 35 LOCAL COMPANIES 10
FIGURE 4: LEADING 35 CORPORATIONS 12
FIGURE 5: MARKET SHARE BY CORPORATE NATIONALITY 14
FIGURE 6: LEADING 15 THERAPEUTIC CLASSES (LEVEL 3) 2015 15
FIGURE 7: 15 FASTEST-GROWING THERAPEUTIC CLASSES (LEVEL 3) 2015 16
FIGURE 8-22: LEADING 15 THERAPEUTIC CLASS PROFILES 17
FIGURE 8: A2B ANTIULCERANTS 17
FIGURE 9: A10P SGLT2 INHIBITOR A-DIABS 18
FIGURE 10: B1B HEPARINS 19
FIGURE 11: B1F DIRECT FACTOR XA INHIBS 20
FIGURE 12: C1C CARD STIM EX CARD GLYCOS 21
FIGURE 13: C10A CHOLESTandTRIGLY.REGULATOR 22
FIGURE 14: D5B SYST ANTIPSORIASIS PRDS 23
FIGURE 15: J5B ANTIVIRALS EXCL ANTI-HIV 24
FIGURE 16: J5C HIV ANTIVIRALS 25
FIGURE 17: L1G MAB ANTINEOPLASTICS 26
FIGURE 18: L1H PROTEIN KINASE INH A-NEO 27
FIGURE 19: L3B INTERFERONS 28
FIGURE 20: L4X OTHER IMMUNOSUPPRESSANTS 29
FIGURE 21: N5A ANTIPSYCHOTICS 30
FIGURE 22: N6A ANTIDEPRESS. and MOOD STAB. 31
FIGURE 23: LEADING 40 PRODUCTS 32
FIGURE 24: LEADING 40 NEW PRODUCTS 34
FIGURE 25: LEADING 15 PRODUCT FORMS 37
FIGURE 26: FASTEST GROWING 40 PRODUCTS SALES TRENDS 38
SECTION 3: APPENDICES 40
APPENDIX 1: AUDITED UNIVERSE 40
APPENDIX 2: COUNTRY SPECIFIC ALERTS 41
APPENDIX 3: MEASURE INDEX 44
APPENDIX 4: SALES DATA MEASURES 46
APPENDIX 5: *LATEST FACTORS 48
APPENDIX 6: QUARTERLY US$ EXCHANGE RATES BY COUNTRY 52
APPENDIX 7: CORPORATIONS 54
APPENDIX 8: PRODUCT NAMES 55
APPENDIX 9: THERAPIES 57
APPENDIX 10: EPHMRA ANATOMICAL THERAPEUTIC CLASSIFICATION 58

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.